122 related articles for article (PubMed ID: 22524849)
1. Clinico-pathological significance of MHC-I type chain-associated protein A expression in oral squamous cell carcinoma.
Wang J; Li C; Yang D; Jian XC; Jiang CH
Asian Pac J Cancer Prev; 2012; 13(2):715-8. PubMed ID: 22524849
[TBL] [Abstract][Full Text] [Related]
2. MICA and MICB overexpression in oral squamous cell carcinoma.
Liu CJ; Lui MT; Chen HL; Lin SC; Chang KW
J Oral Pathol Med; 2007 Jan; 36(1):43-7. PubMed ID: 17181741
[TBL] [Abstract][Full Text] [Related]
3. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
4. [Expression of osteopontin mRNA in oral squamous cell carcinoma and normal oral mucosa].
Lu XZ; Yin XM; Feng YY; Duan LQ; Chen WT; Zhang CP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1165-7. PubMed ID: 18676253
[TBL] [Abstract][Full Text] [Related]
5. ALY as a potential contributor to metastasis in human oral squamous cell carcinoma.
Saito Y; Kasamatsu A; Yamamoto A; Shimizu T; Yokoe H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
J Cancer Res Clin Oncol; 2013 Apr; 139(4):585-94. PubMed ID: 23242234
[TBL] [Abstract][Full Text] [Related]
6. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
[TBL] [Abstract][Full Text] [Related]
7. Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases.
Yamamoto A; Kasamatsu A; Ishige S; Koike K; Saito K; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
J Cancer Res Clin Oncol; 2013 Apr; 139(4):533-42. PubMed ID: 23207790
[TBL] [Abstract][Full Text] [Related]
8. Expression profile of human beta-defensin 3 in oral squamous cell carcinoma.
Kesting MR; Loeffelbein DJ; Hasler RJ; Wolff KD; Rittig A; Schulte M; Hirsch T; Wagenpfeil S; Jacobsen F; Steinstraesser L
Cancer Invest; 2009 Jun; 27(5):575-81. PubMed ID: 19219676
[TBL] [Abstract][Full Text] [Related]
9. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling of CYP1B1 in oral squamous cell carcinoma: counterintuitive downregulation in tumors.
Pradhan S; Nagashri MN; Gopinath KS; Kumar A
PLoS One; 2011; 6(11):e27914. PubMed ID: 22114726
[TBL] [Abstract][Full Text] [Related]
11. Stromelysin-3 expression is an early event in human oral tumorigenesis.
Soni S; Mathur M; Shukla NK; Deo SV; Ralhan R
Int J Cancer; 2003 Nov; 107(2):309-16. PubMed ID: 12949813
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
Ries J; Mollaoglu N; Vairaktaris E; Neukam FW; Nkenke E
Anticancer Res; 2009 Dec; 29(12):5125-30. PubMed ID: 20044626
[TBL] [Abstract][Full Text] [Related]
14. Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Chiang ML; Kuo MY
J Formos Med Assoc; 2013 May; 112(5):253-8. PubMed ID: 23660220
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis.
Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C
Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428
[TBL] [Abstract][Full Text] [Related]
16. The retinoic acid receptor-beta (RAR-beta) mRNA expression in the oral squamous cell carcinoma associated with betel quid use.
Kao SY; Tu HF; Chang KW; Chang CS; Yang CC; Lin SC
J Oral Pathol Med; 2002 Apr; 31(4):220-6. PubMed ID: 12076325
[TBL] [Abstract][Full Text] [Related]
17. Expression of the epidermal growth factor seven-transmembrane member CD97 correlates with grading and staging in human oral squamous cell carcinomas.
Mustafa T; Eckert A; Klonisch T; Kehlen A; Maurer P; Klintschar M; Erhuma M; Zschoyan R; Gimm O; Dralle H; Schubert J; Hoang-Vu C
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):108-19. PubMed ID: 15668483
[TBL] [Abstract][Full Text] [Related]
18. A loss of profilin-1 in late-stage oral squamous cell carcinoma.
Adami GR; O'Callaghan TN; Kolokythas A; Cabay RJ; Zhou Y; Schwartz JL
J Oral Pathol Med; 2017 Aug; 46(7):489-495. PubMed ID: 27862305
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary study on the role of voltage-gated sodium channel subtype Nav1.5 in lymph node metastasis of oral squamous cell carcinoma].
Liu WJ; Xu L; Zhu XW; Chen XF; Wang H; Jiang Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Mar; 52(3):188-193. PubMed ID: 28279058
[No Abstract] [Full Text] [Related]
20. Loss of keratin 8 phosphorylation leads to increased tumor progression and correlates with clinico-pathological parameters of OSCC patients.
Alam H; Gangadaran P; Bhate AV; Chaukar DA; Sawant SS; Tiwari R; Bobade J; Kannan S; D'cruz AK; Kane S; Vaidya MM
PLoS One; 2011; 6(11):e27767. PubMed ID: 22114688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
